APEX Trial: Difference between revisions

Jump to navigation Jump to search
(Replaced content with "==Overview== The APEX Trial is a trial of the Factor Xa inhibitor betrixaban in the management of medically ill patients. ==Investigators== Principal Investigato...")
No edit summary
 
Line 1: Line 1:
==Overview==
==Overview==
The APEX Trial is a trial of the [[Factor Xa inhibitor]] [[betrixaban]] in the management of medically ill patients.
The APEX Trial is a trial of the [[Factor Xa inhibitor]] [[betrixaban]] in the management of medically ill patients.
==Investigators==
Principal Investigators for the APEX Trial include the following:

Latest revision as of 15:38, 19 June 2013

Overview

The APEX Trial is a trial of the Factor Xa inhibitor betrixaban in the management of medically ill patients.